Oct 18, 2020 | Wealth Management
In the last few days, Johnson & Johnson’s vaccine study was paused after a volunteer got sick and Eli Lilly & Co.’s antibody study was halted enrollment over a safety concern. AstraZeneca Plc’s vaccine has been on hold since early September. Only Pfizer still...
Oct 11, 2020 | Wealth Management
Last year, the yield curve inverted and sent chills down investors’ spines. Since then, we have indeed fallen into a recession, but one driven by the pandemic. Now, the yield curve is showing what else it can do. Currently, bear steepening has taken hold – which...
Sep 20, 2020 | Wealth Management
The Department of Labor (DOL) recently issued guidance allowing employers to add retirement funds into their 401K investment lineup that invest in private equity. Private-equity funds, which fall into the broader category of alternative investments, have only been...
Sep 6, 2020 | Wealth Management
US Debt levels hit a postwar record this week and the debt surpassed 100% of GDP for the April to June quarter. That would put the US in the company of a esoteric few – Japan, Italy and Greece. In the meantime, the Dow briefly topped 29000 before pulling back...
Aug 23, 2020 | Wealth Management
With the Democratic National Convention behind us and the Republican National Convention set to nominate Donald Trump for the Presidential Election in November, Wall Street has all but given up on monitoring corporate earnings and its entire focus is now on who will...
Aug 16, 2020 | Wealth Management
With the market edging higher and the prospect of combative presidential debates to start soon, speculation is running rampant on how a Biden victory could impact the stock market. On the one hand, there are those who believe that the prospect of raising taxes and...
